Journal of Clinical Endocrinology & Metabolism, Vol 55, 858-861, Copyright © 1982 by Endocrine Society

ARTICLES

Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies

DM Wilson, A Bennett, GD Adamson, RJ Nagashima, F Liu, ML DeNatale, RL Hintz and RG Rosenfeld

To explore the role of the somatomedins (SM) during human pregnancy, we have measured plasma levels of insulin-like growth factor I (IGF-I), IGF-II, and SM peptide content (SMPC) in 79 women in various stages of normal pregnancies. IGF-I and IGF-II were measured by specific RIAs, and SMPC was measured by a radioreceptor assay using human placental membranes. IGF-I and SMPC rose during pregnancy, showing a significant positive correlation with the length of gestation. Plasma levels of IGF- I in the third trimester averaged 324 ng/ml, a 33% increase over the first trimester average of 243 ng/ml (P less than 0.05). Although IGF- II did not correlate with the length of gestation, the third trimester average was significantly higher than the first trimester average (780 vs. 630 ng/ml; P less than 0.05). After delivery, both IGF-I and IGF-II levels rapidly dropped to levels significantly below those seen in the third trimester. The gestational rise in SMPC and plasma levels of both IGF-I and IGF-II supports the hypothesis that SM play a role in the regulation of fetal growth.

This article has been cited by other articles:

				A. N. Sferruzzi-Perri, J. A. Owens, P. Standen, R. L. Taylor, G. K. Heinemann, J. S. Robinson, and C. T. Roberts Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E668 - E676. [Abstract] [Full Text] [PDF]

				V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]

				K. O O'Brien, C. M Donangelo, C. L V. Zapata, S. A Abrams, E M. Spencer, and J. C King Bone calcium turnover during pregnancy and lactation in women with low calcium diets is associated with calcium intake and circulating insulin-like growth factor 1 concentrations Am. J. Clinical Nutrition, February 1, 2006; 83(2): 317 - 323. [Abstract] [Full Text] [PDF]

				S. Bhatia, G. H. Faessen, G. Carland, R. L. Balise, S. E. Gargosky, M. Druzin, Y. El-Sayed, D. M. Wilson, and L. C. Giudice A Longitudinal Analysis of Maternal Serum Insulin-Like Growth Factor I (IGF-I) and Total and Nonphosphorylated IGF-Binding Protein-1 in Human Pregnancies Complicated by Intrauterine Growth Restriction J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1864 - 1870. [Abstract] [Full Text] [PDF]

				M. Sowers, T. Scholl, J. Grewal, X. Chen, and M. Jannausch IGF-I, Osteocalcin, and Bone Change in Pregnant Normotensive and Pre-Eclamptic Women J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5898 - 5903. [Abstract] [Full Text] [PDF]

				R. C. Baxter What Is the Significance of IGF-Binding Protein-3 Proteolysis in the Circulation? J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5087 - 5088. [Full Text] [PDF]

				T. R. H. Regnault, S. W. Limesand, and W. W. Hay Jr Factors Influencing Fetal Growth NeoReviews, June 1, 2001; 2(6): e119 - 128. [Full Text] [PDF]

				V. Herman-Bonert, M. Seliverstov, and S. Melmed Pregnancy in Acromegaly: Successful Therapeutic Outcome J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 727 - 731. [Full Text]

				J. P. Miell, K. S. Langford, J. S. Jones, P. Noble, M. Westwood, A. White, and K. H. Nicolaides The Maternal Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Response to Trisomic Pregnancy during the First Trimester: A Possible Diagnostic Tool for Trisomy 18 Pregnancies J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 287 - 292. [Abstract] [Full Text] [PDF]